X-ray-responsive polypeptide nanogel for concurrent chemoradiotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
X-ray-responsive polypeptide nanogel for concurrent chemoradiotherapy
Authors
Keywords
Polypeptide nanogel, Diselenide bond, X-ray-responsiveness, Chemoradiotherapy, Cancer therapy
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 332, Issue -, Pages 1-9
Publisher
Elsevier BV
Online
2021-02-07
DOI
10.1016/j.jconrel.2021.02.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer
- (2020) D. De Ruysscher et al. ANNALS OF ONCOLOGY
- A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
- (2020) Jonathan Peng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis
- (2020) Jianfeng Guo et al. ACS Nano
- Controlled synthesis of polypeptides
- (2020) Yang Liu et al. CHINESE CHEMICAL LETTERS
- Stimuli-Responsive Small-on-Large Nanoradiosensitizer for Enhanced Tumor Penetration and Radiotherapy Sensitization
- (2020) Wenhui Fu et al. ACS Nano
- Synergistic Local Combination of Radiation and Anti-Programmed Death Ligand 1 Immunotherapy Using Radiation-Responsive Splintery Metallic Nanocarriers
- (2020) Bongseo Choi et al. ACS Nano
- A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence
- (2020) Tianjun Zhou et al. ACS Nano
- What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
- (2020) Duxin Sun et al. ACS Nano
- A Multistage Cooperative Nanoplatform Enables Intracellular Co‐Delivery of Proteins and Chemotherapeutics for Cancer Therapy
- (2020) Peng Zhang et al. ADVANCED MATERIALS
- DIAPH1 Is Upregulated and Inhibits Cell Apoptosis through ATR/p53/Caspase-3 Signaling Pathway in Laryngeal Squamous Cell Carcinoma
- (2019) Jiechao Yang et al. DISEASE MARKERS
- Role of Nanoparticle Mechanical Properties in Cancer Drug Delivery
- (2019) Yue Hui et al. ACS Nano
- Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications
- (2019) Raziye Mohammadpour et al. ADVANCED DRUG DELIVERY REVIEWS
- Biologically Targeted Photo-Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion
- (2019) Yu Mi et al. ADVANCED DRUG DELIVERY REVIEWS
- Toward early cancer detection: Focus on biosensing systems and biosensors for an anti-apoptotic protein survivin and survivin mRNA
- (2019) Magdalena Stobiecka et al. BIOSENSORS & BIOELECTRONICS
- PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment
- (2019) Amir Iravani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
- (2019) Narittee Sukswai et al. Current Hematologic Malignancy Reports
- pH‐Responsive PEG‐Shedding and Targeting Peptide‐Modified Nanoparticles for Dual‐Delivery of Irinotecan and microRNA to Enhance Tumor‐Specific Therapy
- (2019) Vivian Juang et al. Small
- Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery
- (2019) Pan Zheng et al. CHINESE CHEMICAL LETTERS
- Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
- (2019) Jeffrey D. Bradley et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial
- (2018) Andreas Hallqvist et al. LUNG CANCER
- Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1
- (2018) Lihong Wang-Bishop et al. GASTROENTEROLOGY
- Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database
- (2018) Eric D Miller et al. Radiation Oncology
- The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)
- (2018) Judi van Diessen et al. RADIOTHERAPY AND ONCOLOGY
- Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non–Small Cell Lung Cancer
- (2018) Steven E. Schild et al. Journal of Thoracic Oncology
- From the Cover: Metabolism Modulation in Different Organs by Silver Nanoparticles: An NMR Metabolomics Study of a Mouse Model
- (2017) Ivana Jarak et al. TOXICOLOGICAL SCIENCES
- Ultra-sensitive ROS-responsive tellurium-containing polymers
- (2015) Wei Cao et al. CHEMICAL COMMUNICATIONS
- A γ-ray and dual redox-responsive supramolecular polymer constructed by a selenium containing pillar[5]arene dimer and a neutral guest
- (2015) Yujuan Zhou et al. CHEMICAL COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation